Pharmacology & ToxicologybioRxiv
Virtual drug screen reveals context-dependent inhibition of cardiomyocyte hypertrophy
T. G. Eggertsen, J. J. Saucerman
This paper uses a computational model to screen FDA-approved drugs for their ability to inhibit cardiomyocyte hypertrophy, identifying midostaurin as a context-dependent inhibitor.
DOI 10.1111/bph.16163